Swiss National Bank’s Supernus Pharmaceuticals SUPN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.37M | Hold |
107,000
| – | – | ﹤0.01% | 1497 |
|
|
2025
Q1 | $3.5M | Sell |
107,000
-1,400
| -1% | -$45.9K | ﹤0.01% | 1455 |
|
|
2024
Q4 | $3.92M | Buy |
108,400
+800
| +0.7% | +$28.9K | ﹤0.01% | 1476 |
|
|
2024
Q3 | $3.35M | Hold |
107,600
| – | – | ﹤0.01% | 1562 |
|
|
2024
Q2 | $2.88M | Hold |
107,600
| – | – | ﹤0.01% | 1614 |
|
|
2024
Q1 | $3.67M | Hold |
107,600
| – | – | ﹤0.01% | 1495 |
|
|
2023
Q4 | $3.11M | Sell |
107,600
-12,100
| -10% | -$350K | ﹤0.01% | 1592 |
|
|
2023
Q3 | $3.3M | Buy |
119,700
+1,300
| +1% | +$35.8K | ﹤0.01% | 1528 |
|
|
2023
Q2 | $3.56M | Buy |
118,400
+1,800
| +2% | +$54.1K | ﹤0.01% | 1516 |
|
|
2023
Q1 | $4.22M | Sell |
116,600
-12,600
| -10% | -$456K | ﹤0.01% | 1382 |
|
|
2022
Q4 | $4.61M | Buy |
129,200
+2,500
| +2% | +$89.2K | ﹤0.01% | 1365 |
|
|
2022
Q3 | $4.29M | Buy |
126,700
+1,000
| +0.8% | +$33.9K | ﹤0.01% | 1372 |
|
|
2022
Q2 | $3.64M | Hold |
125,700
| – | – | ﹤0.01% | 1507 |
|
|
2022
Q1 | $4.06M | Buy |
125,700
+8,600
| +7% | +$278K | ﹤0.01% | 1577 |
|
|
2021
Q4 | $3.42M | Hold |
117,100
| – | – | ﹤0.01% | 1712 |
|
|
2021
Q3 | $3.12M | Buy |
117,100
+1,000
| +0.9% | +$26.7K | ﹤0.01% | 1757 |
|
|
2021
Q2 | $3.58M | Sell |
116,100
-4,300
| -4% | -$132K | ﹤0.01% | 1725 |
|
|
2021
Q1 | $3.15M | Buy |
120,400
+1,300
| +1% | +$34K | ﹤0.01% | 1733 |
|
|
2020
Q4 | $3M | Hold |
119,100
| – | – | ﹤0.01% | 1678 |
|
|
2020
Q3 | $2.48M | Buy |
119,100
+2,000
| +2% | +$41.7K | ﹤0.01% | 1613 |
|
|
2020
Q2 | $2.78M | Buy |
117,100
+15,400
| +15% | +$366K | ﹤0.01% | 1522 |
|
|
2020
Q1 | $1.83M | Buy |
101,700
+1,300
| +1% | +$23.4K | ﹤0.01% | 1510 |
|
|
2019
Q4 | $2.38M | Buy |
100,400
+2,000
| +2% | +$47.4K | ﹤0.01% | 1630 |
|
|
2019
Q3 | $2.7M | Buy |
98,400
+1,100
| +1% | +$30.2K | ﹤0.01% | 1484 |
|
|
2019
Q2 | $3.22M | Buy |
97,300
+2,100
| +2% | +$69.5K | ﹤0.01% | 1395 |
|
|
2019
Q1 | $3.34M | Buy |
95,200
+2,900
| +3% | +$102K | ﹤0.01% | 1342 |
|
|
2018
Q4 | $3.07M | Buy |
92,300
+2,100
| +2% | +$69.8K | ﹤0.01% | 1292 |
|
|
2018
Q3 | $4.54M | Hold |
90,200
| – | – | 0.01% | 1181 |
|
|
2018
Q2 | $5.4M | Buy |
90,200
+1,800
| +2% | +$108K | 0.01% | 1039 |
|
|
2018
Q1 | $4.05M | Buy |
88,400
+2,000
| +2% | +$91.6K | ﹤0.01% | 1176 |
|
|
2017
Q4 | $3.44M | Buy |
86,400
+2,900
| +3% | +$116K | ﹤0.01% | 1288 |
|
|
2017
Q3 | $3.34M | Hold |
83,500
| – | – | ﹤0.01% | 1290 |
|
|
2017
Q2 | $3.6M | Buy |
83,500
+18,200
| +28% | +$784K | ﹤0.01% | 1208 |
|
|
2017
Q1 | $2.04M | Buy |
65,300
+2,100
| +3% | +$65.7K | ﹤0.01% | 1545 |
|
|
2016
Q4 | $1.6M | Hold |
63,200
| – | – | ﹤0.01% | 1725 |
|
|
2016
Q3 | $1.56M | Sell |
63,200
-1,800
| -3% | -$44.5K | ﹤0.01% | 1672 |
|
|
2016
Q2 | $1.32M | Buy |
65,000
+8,700
| +15% | +$177K | ﹤0.01% | 1794 |
|
|
2016
Q1 | $830K | Buy |
56,300
+10,300
| +22% | +$152K | ﹤0.01% | 2022 |
|
|
2015
Q4 | $618K | Hold |
46,000
| – | – | ﹤0.01% | 2134 |
|
|
2015
Q3 | $645K | Buy |
46,000
+6,200
| +16% | +$86.9K | ﹤0.01% | 2041 |
|
|
2015
Q2 | $676K | Buy |
+39,800
| New | +$676K | ﹤0.01% | 2049 |
|